2023 House Bill 4366

Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for.

A bill to amend 2019 PA 39, entitled “Administration of opioid antagonists act,” by amending the title and sections 103 and 107 (MCL 15.673 and 15.677), section 107 as amended by 2020 PA 321, and by adding section 106.

AI Analysis – Experimental

The bill seeks to enable certain employees or agents to carry, administer, and distribute opioid antagonists under specific conditions, ensuring access to these life-saving drugs by certain agencies and their personnel. It proposes to limit the civil and criminal liability for these agencies and individuals regarding the possession, distribution, and use of opioid antagonists, provided their actions do not constitute gross negligence or willful misconduct.

Introduced in the House

April 11, 2023

Introduced by Rep. Curtis VanderWall (R-102) and six co-sponsors

Co-sponsored by Reps. Joseph Aragona (R-60), Brian BeGole (R-71), Jennifer Conlin (D-48), Jim Haadsma (D-44), Robert Bezotte (R-50) and Pat Outman (R-91)

Referred to the Committee on Health Policy